Skip to the main content.

1 min read

NanoSight Nanoparticle Tracking Analysis (NTA)

NTA analysis is a technique capable of sizing and quantifying nanoparticles through the use of light scattering. Unlike traditional dynamic light scattering, a CCD camera is used to track the movement of individual nanoparticles in real time, and the system derives their hydrodynamic radius through the Stokes-Einstein equation. Nanosight also goes beyond DLS in that it explicitly quantifies particles below 1 micron and can more accurately characterize polydisperse samples.

The importance of characterizing particles in the nanoparticle range was recently highlighted in a publication from CDER in which NTA was used to evaluate differences in erythropoietin peptide mimetic products which were associated with severe adverse postmarketing events (Kotarek et.al, J. Pharm.Sci. 2016, 1-5). The particle core recommends NTA to complement MFI analysis and bridge the gap below 1 micron for particle characterization and enumeration.Nanosight would be a valuable technique to monitor monomer and aggregation formation in the ≤ 1 micron size range.

For proteinaceous particles, NTA has proven to be useful to characterize and quantify particles down to 50 nm in size. The optimal concentration range for NTA is 106 to 109 particles/mL.

More on NanoSight

1 min read

KBI Biopharma Named "Best CMO in Asia" at BioPharma Asia, 2017

KBI Biopharma Named "Best CMO in Asia" at BioPharma Asia, 2017 KBI Biopharma was selected as the "Best CMO in Asia" in the Biopharma Industry Awards...

Read More
Navigating a New Standard in Microbial Protein Expression

Navigating a New Standard in Microbial Protein Expression

At KBI Biopharma, our PUREplatform™ is everything you need to make a protein. Catered to your needs, our service package contains plasmids, strains,...

Read More

1 min read

Novel Constructs

Technology continues to expand the possibilities of biopharmaceuticals, and many of the therapies being developed to meet patient needs in the new...

Read More